Skip to main content
SpringerLink
Log in

Imaging for the Diagnosis and Staging of IBC

  • Chapter
  • First Online:
Inflammatory Breast Cancer: An Update

  • 846 Accesses

Abstract

The role of imaging in the diagnosis and assessment of inflammatory breast cancer (IBC) includes characterization of the known tumor, delineation of loco-regional disease extent in the ipsilateral and contralateral breasts and regional lymph node basins, diagnosis of distant metastases, and evaluation of response to neoadjuvant treatment. In this chapter, we review the role of conventional imaging modalities, including mammography and sonography, in the diagnosis and assessment of IBC. We also discuss the potential use of evolving imaging modalities, such as magnetic resonance imaging, positron emission tomography, and combined positron emission tomography and computed tomography, in patients diagnosed with IBC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CT:

Computed tomography

IBC:

Inflammatory breast cancer

MRI:

Magnetic resonance imaging

PET:

Positron emission tomography

LABC:

Locally advanced breast cancer

References

  1. Levine PH, Steinhorn SC, Ries LG et al (1985) Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst 74:291–297

    PubMed  CAS  Google Scholar 

  2. Chang S, Parker SL, Pham T et al (1998) Inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975–1992. Cancer 82:2366–2372

    Article  PubMed  CAS  Google Scholar 

  3. Hance KW, Anderson WF, Devesa SS et al (2005) Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 97:966–975

    Article  PubMed  Google Scholar 

  4. Greene FL, Page DL, Fleming ID et al (2002) American Joint Cancer Committee cancer staging manual, 6th edn. Springer, New York, pp 221–240

    Google Scholar 

  5. Lee B, Tannenbaum N (1924) Inflammatory carcinoma of the breast: a report of twenty-eight cases from the breast clinic of Memorial Hospital. Surg Gynecol Obstet 39:580–585

    Google Scholar 

  6. Jaiyesimi IA, Buzdar AU, Hortobagyi G (1992) Inflammatory breast cancer: a review. J Clin Oncol 10:1014–1024

    PubMed  CAS  Google Scholar 

  7. Dirix LY, Dam PV, Prove A et al (2006) Inflammatory breast cancer: current understanding. Curr Opin Oncol 18:563–571

    Article  PubMed  CAS  Google Scholar 

  8. Wingo PA, Jamison PM, Young JL et al (2004) Population-based statistics for women diagnosed with inflammatory breast cancer (United States). Cancer Causes Control 15:321–328

    Article  PubMed  Google Scholar 

  9. Chow CK (2005) Imaging in inflammatory breast carcinoma. Breast Dis 22:45–54

    PubMed  Google Scholar 

  10. Dershaw DD, Moore MP, Liberman L et al (1994) Inflammatory breast carcinoma: ­mammographic findings. Radiology 190:831–834

    PubMed  CAS  Google Scholar 

  11. Droulias CA, Sewell CW, McSweeney MB et al (1976) Inflammatory carcinoma of the breast: a correlation of clinical, radiologic and pathologic findings. Ann Surg 184:217–222

    Article  PubMed  CAS  Google Scholar 

  12. Gunhan-Bilgen I, Ustun EE, Memis A (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223:829–838

    Article  PubMed  Google Scholar 

  13. Kushwaha AC, Whitman GJ, Stelling CB et al (2000) Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol 174:535–538

    PubMed  CAS  Google Scholar 

  14. Caumo F, Gaioni MB, Bonetti F et al (2005) Occult inflammatory breast cancer: review of clinical, mammographic, US and pathologic signs. Radiol Med 109:308–320

    PubMed  Google Scholar 

  15. Tardivon AA, Viala J, Corvellec Rudelli A et al (1997) Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol 24:124–130

    Article  PubMed  CAS  Google Scholar 

  16. Lee KW, Chung SY, Yang I et al (2005) Inflammatory breast cancer: imaging findings. Clin Imaging 29:22–25

    PubMed  Google Scholar 

  17. Yang WT, Le-Petross HT, Macapinlac H et al (2008) Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 109:417–426

    Article  PubMed  CAS  Google Scholar 

  18. Haagensen CD (1971) Diseases of the breast, 2nd edn. Saunders, Philadelphia, pp 576–584

    Google Scholar 

  19. Taylor GW, Meltzer A (1938) Inflammatory carcinoma of the breast. Am J Cancer 133:33–49

    Google Scholar 

  20. Yang WT, Lane DL, Le-Petross HT et al (2007) Breast lymphoma: imaging findings of 32 tumors in 27 patients. Radiology 245:692–702

    Article  PubMed  Google Scholar 

  21. Yang WT, Muttarak M, Ho L (2000) Nonmammary malignancies of the breast: ultrasound, CT, and MRI. Semin Ultrasound CT MR 21:375–394

    Article  PubMed  CAS  Google Scholar 

  22. Belli P, Costantini M, Romani M et al (2002) Role of magnetic resonance imaging in inflammatory carcinoma of the breast. Rays 27:299–305

    PubMed  Google Scholar 

  23. Renz DM, Baltzer PA, Bottcher J et al (2008) Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol 18:2370–2380

    Article  PubMed  Google Scholar 

  24. Yang WT, Ahuja A, Tang A et al (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 16:241–246

    Google Scholar 

  25. Vlastos G, Fornage BD, Mirza NQ et al (2000) The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg 179:446–452

    Article  PubMed  CAS  Google Scholar 

  26. Rieber A, Tomczak RJ, Mergo PJ et al (1997) MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput Assist Tomogr 21:128–132

    Article  PubMed  CAS  Google Scholar 

  27. Le-Petross HT, Cristofanilli C, Carkaci S et al (2011) MRI features of inflammatory breast cancer. AJR Am J Roentgenol 197: W769– W776

    Google Scholar 

  28. Carbognin G, Calciolari C, Girardi V et al (2010) Inflammatory breast cancer: MR imaging findings. Radiol Med 115:70–82

    Article  PubMed  CAS  Google Scholar 

  29. Girardi V, Carbognin G, Camera L et al (2011) Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging. Radiol Med 116:71–83

    Article  PubMed  CAS  Google Scholar 

  30. Walshe JM, Swain SM (2005) Clinical aspects of inflammatory breast cancer. Breast Dis 22:35–44

    PubMed  Google Scholar 

  31. Anderson WF, Chu KC, Chang S (2003) Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol 21:2254–2259

    Article  PubMed  Google Scholar 

  32. Thukral A, Thomasson DM, Chow CK et al (2007) Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab – initial experience. Radiology 244:727–735

    Article  PubMed  Google Scholar 

  33. Wahl RL, Siegel BA, Coleman RE et al (2004) Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group. J Clin Oncol 2:277–285

    Google Scholar 

  34. Eubank WB, Mankoff DA (2005) Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 35:84–99

    Article  PubMed  Google Scholar 

  35. Osman MM, Cohade C, Nakamoto Y et al (2003) Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 44:240–243

    PubMed  Google Scholar 

  36. Baslaim MM, Bakheet SM, Bakheet R et al (2003) 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg 27:1099–1104

    Article  PubMed  Google Scholar 

  37. Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379

    PubMed  CAS  Google Scholar 

  38. Townsend DW, Beyer T (2002) A combined PET/CT scanner: the path to true image fusion. Br J Radiol 75(suppl):24–30

    Google Scholar 

  39. Fueger BJ, Weber WA, Quon A et al (2005) Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol 7:369–376

    Article  PubMed  Google Scholar 

  40. Carkaci S, Macapinlac HA, Cristofanilli M et al (2009) Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 50:231–238

    Article  PubMed  Google Scholar 

  41. Rousseau C, Devillers A, Sagan C et al (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F] fluorodeoxyglucose positron emission tomography. J Clin Oncol 24:5366–5372

    Article  PubMed  Google Scholar 

  42. Larson SM, Erdi Y, Akhurst T et al (1999) Tumor treatment based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imaging 2:159–171

    Article  PubMed  Google Scholar 

  43. Krak NC, Hoekstra OS, Lammertsma AA (2004) Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations. Eur J Nucl Med Mol Imaging 31(Suppl 1):S103–S111

    Article  PubMed  Google Scholar 

  44. Rosen EL, Eubank WB, Mankoff DA (2007) FDG PET, PET/CT, and breast cancer imaging. Radiographics 27(Suppl 1):S215–S229

    Article  PubMed  Google Scholar 

  45. Lim HS, Yoon W, Chung TW et al (2007) FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. Radiographics 27(Suppl 1):S197–S213

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, TX, USA

    Wei Tse Yang M.D.

Authors
  1. Wei Tse Yang M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Tse Yang M.D. .

Editor information

Editors and Affiliations

  1. MD Anderson Cancer Center, Dept. Breast Medical Oncology, University of Texas, Holcombe Blvd. 1515, Houston, 77030-4095, Texas, USA

    Naoto T. Ueno

  2. Fox Chase Cancer Center, Cottman Avenue; Room C315 333, Philadelphia, 19111, Pennsylvania, USA

    Massimo Cristofanilli

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Yang, W.T. (2012). Imaging for the Diagnosis and Staging of IBC. In: Ueno, N., Cristofanilli, M. (eds) Inflammatory Breast Cancer: An Update. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-3907-9_6

Download citation

Publish with us

Policies and ethics

Search

Navigation